Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Materials Today. Bio|November 24, 2025
Photothermal-triggered non-apoptotic regulated cell death-related pathway regulation boosts systemic antitumor immunityYanting Liang, Haitao Yuan, Qiu Jin, et al.
Computer Methods and Programs in Biomedicine|July 10, 2023
Machine learning-based intradialytic hypotension prediction of patients undergoing hemodialysis: A multicenter retrospective studyJingjing Dong, Kang Wang, Jingquan He, et al.
Renal Failure|September 10, 2024
Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K)Haijiao Jin, Renhua Lu, Lihong Zhang, et al.
BMC Nephrology|August 9, 2023
Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K)Zhaohui Ni, Haijiao Jin, Renhua Lu, et al.
BMJ Open|December 23, 2021
Hyperkalaemia prevalence, recurrence and treatment in patients on haemodialysis in China: protocol for a prospective multicentre cohort study (PRECEDE-K)Zhaohui Ni, Haijiao Jin, Renhua Lu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 4, 2017
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in ChinaNan Chen, Jiaqi Qian, Jianghua Chen, et al.
Clinical Therapeutics|June 29, 2023
DIALIZE China: A Phase IIIb, Randomized, Placebo-Controlled Study to Reduce Predialysis Hyperkalemia With Sodium Zirconium Cyclosilicate in Chinese PatientsZhaohui Ni, Renhua Lu, Xudong Xu, et al.
Kidney & Blood Pressure Research|November 15, 2017
Risk Factor Analysis for AKI Including Laboratory Indicators: a Nationwide Multicenter Study of Hospitalized PatientsSasa Nie, Zhe Feng, Li Tang, et al.
JAMA Network Open|March 14, 2025
Mizoribine or Cyclophosphamide for Lupus Nephritis: A Randomized Clinical TrialZheyi Dong, Ping Luo, Shiren Sun, et al.
Pageof 9